In Vitro and In Vivo Diagnostic Substances - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the In industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

In Vitro and In Vivo Diagnostic Substances - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - In Vitro and In Vivo Diagnostic Substances
Corporate Insider Buy Sell Ratio (Insider Count) - In Vitro and In Vivo Diagnostic Substances
In Vitro and In Vivo Diagnostic Substances - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2025-12-15 LNTH / Lantheus Holdings, Inc. 4 Morgan Amanda Michelle F - Taxes D 66.57 -368
2025-12-12 NTLA / Intellia Therapeutics, Inc. 4 LEONARD JOHN M. M - Exercise D 6.83 8,557
2025-12-12 BMRA / Biomerica, Inc. 4 BARBIERI ALLEN A - Award D 30,000
2025-12-12 BMRA / Biomerica, Inc. 4 Irani Zackary S. A - Award D 52,500
2025-12-12 BMRA / Biomerica, Inc. 4 MOATAZEDI DAVID A - Award D 20,000
2025-12-12 BMRA / Biomerica, Inc. 4 Gary M. Huff A - Award D 20,000
2025-12-12 BMRA / Biomerica, Inc. 4 Chin Eric A - Award D 22,500
2025-12-12 BMRA / Biomerica, Inc. 4 Lu Gary A - Award D 40,000
2025-12-11 NTLA / Intellia Therapeutics, Inc. 4 LEONARD JOHN M. S - Sale D 9.59 -5,355
2025-12-11 NTLA / Intellia Therapeutics, Inc. 4 LEONARD JOHN M. S - Sale D 9.47 -32,832
2025-12-11 NTLA / Intellia Therapeutics, Inc. 4 LEONARD JOHN M. S - Sale D 9.49 -49,959
2025-12-11 NTLA / Intellia Therapeutics, Inc. 4 LEONARD JOHN M. M - Exercise D 6.83 49,959
2025-12-11 MYGN / Myriad Genetics, Inc. 4 Raha Samraat S. F - Taxes D 7.30 -29,634
2025-12-04 CLDX / Celldex Therapeutics, Inc. 4 Jimenez Freddy A. S - Sale D 29.095 -4,166
2025-12-04 ICCC / ImmuCell Corporation 4/A te Boekhorst Paul Francis Olivier P - Purchase D 5.50020 2,432
2025-12-03 ICCC / ImmuCell Corporation 4 te Boekhorst Paul Francis Olivier P - Purchase D 5.003 2,556
2025-12-03 ICCC / ImmuCell Corporation 4 te Boekhorst Paul Francis Olivier P - Purchase D 5.0406 3,521
2025-12-03 ICCC / ImmuCell Corporation 4/A te Boekhorst Paul Francis Olivier P - Purchase D 5.045 3,598
2025-12-02 ICCC / ImmuCell Corporation 4 te Boekhorst Paul Francis Olivier P - Purchase D 4.8686 3,708
2025-12-01 NEOG / Neogen Corporation 4 Naemura David H. M - Exercise D 5.98 12,912
2025-12-01 NEOG / Neogen Corporation 4 Naemura David H. F - Taxes D 5.98 -3,548
2025-11-25 ICCC / ImmuCell Corporation 4 Tomsche David Scott By Spouse P - Purchase I 4.765 1,633
2025-11-25 ICCC / ImmuCell Corporation 4 Tomsche David Scott P - Purchase D 4.76 1,633
2025-11-17 VNRX / VolitionRx Limited 4 Reynolds Cameron John P - Purchase D 0.35 20,000
2025-11-17 LNTH / Lantheus Holdings, Inc. 4 Heino Mary Anne A - Award D 14,285
2025-11-14 QCLS / Q/C Technologies, Inc. 4 White Billy Joe A - Award D 22,839
2025-11-14 QCLS / Q/C Technologies, Inc. 4 Glass Mitchell A - Award D 11,420
2025-11-14 QCLS / Q/C Technologies, Inc. 4 RAUCH GARY M A - Award D 11,420
2025-11-14 QCLS / Q/C Technologies, Inc. 4 Bernstein Bruce A - Award D 25,000
2025-11-14 QCLS / Q/C Technologies, Inc. 4 Silverman Joshua A - Award D 91,356
2025-11-14 QCLS / Q/C Technologies, Inc. 4 Friscia Stephen A - Award D 22,839
2025-11-13 CLDX / Celldex Therapeutics, Inc. 4 Wright Richard M. S - Sale D 24.0005 -49,298
2025-11-13 CLDX / Celldex Therapeutics, Inc. 4 Wright Richard M. M - Exercise D 22.48 15,750
2025-11-13 CLDX / Celldex Therapeutics, Inc. 4 Wright Richard M. M - Exercise D 10.38 26,672
2025-11-13 CLDX / Celldex Therapeutics, Inc. 4 Wright Richard M. M - Exercise D 9.0165 6,876
2025-11-07 IDXX / IDEXX Laboratories, Inc. 4 Hunt Nimrata S - Sale D 702.2017 -5,114
2025-11-07 IDXX / IDEXX Laboratories, Inc. 4 Hunt Nimrata S - Sale D 704.8659 -1,468
2025-11-07 IDXX / IDEXX Laboratories, Inc. 4 Hunt Nimrata S - Sale D 703.7339 -1,465
2025-11-07 IDXX / IDEXX Laboratories, Inc. 4 Hunt Nimrata S - Sale D 705.5448 -1,378
2025-11-07 IDXX / IDEXX Laboratories, Inc. 4 Hunt Nimrata M - Exercise D 505.53 5,405
2025-11-07 IDXX / IDEXX Laboratories, Inc. 4 Hunt Nimrata M - Exercise D 288.78 7,125
2025-11-03 NEOG / Neogen Corporation 4 Nassif Mikheal By son P - Purchase I 6.25 177
2025-11-03 NEOG / Neogen Corporation 4 Riggsbee Richard Bryan A - Award D 6.29 178,855
2025-11-01 VNRX / VolitionRx Limited 4 Butera Salvatore Thomas F - Taxes D 0.434 -4,648
2025-11-01 VNRX / VolitionRx Limited 4 Retter Andrew F - Taxes D 0.434 -4,588
2025-11-01 VNRX / VolitionRx Limited 4 Plummer Nicholas F - Taxes D 0.434 -5,647
2025-11-01 VNRX / VolitionRx Limited 4 Forterre Gael F - Taxes D 0.434 -1,753
2025-11-01 VNRX / VolitionRx Limited 4 Rootsaert Rodney Gerard F - Taxes D 0.434 -3,197
2025-10-31 IMDX / Insight Molecular Diagnostics Inc. 4 James Andrea S. M - Exercise D 50,000
2025-10-31 IMDX / Insight Molecular Diagnostics Inc. 4/A James Andrea S. M - Exercise D 50,000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)